Rhonda B. Levin
Vertex Pharmaceuticals (United States)(US)
Publications by Year
Research Areas
HIV/AIDS drug development and treatment, HIV Research and Treatment, Hepatitis C virus research, Computational Drug Discovery Methods, Monoclonal and Polyclonal Antibodies Research
Most-Cited Works
- → L-735,524: an orally bioavailable human immunodeficiency virus type 1 protease inhibitor.(1994)526 cited
- → L-735,524: The Design of a Potent and Orally Bioavailable HIV Protease Inhibitor(1994)408 cited
- → A priori prediction of activity for HIV-1 protease inhibitors employing energy minimization in the active site(1995)228 cited
- → Inhibitors of hepatitis C virus NS3·4A protease 2. Warhead SAR and optimization(2004)63 cited
- → Identification of MK-944a: A Second Clinical Candidate from the Hydroxylaminepentanamide Isostere Series of HIV Protease Inhibitors(2000)55 cited
- → Synthesis and evaluation of 2-pyridinone derivatives as HIV-1 specific reverse transcriptase inhibitors. 1. Phthalimidoalkyl and -alkylamino analogs(1992)50 cited
- → Inhibitors of hepatitis C virus NS3·4A protease 1. Non-Charged tetrapeptide variants(2003)40 cited
- → Synthesis and evaluation of pyridyl analogs of L-735,524: Potent HIV-1 protease inhibitors(1994)22 cited
- → Synthesis, antiviral activity, and bioavailability studies of γ-lactam derived HIV protease inhibitors(1994)19 cited
- → A Priori Prediction of Activity for HIV-1 Protease Inhibitors Employing Energy Minimization in the Active Site(1996)2 cited